A process for making a combination vaccine comprising type 1 poliovirus inactivated for immunizing a human host, comprising the steps of: mixing diphtheria toxoid and tetanus toxoid, followed by the addition of inactivated poliovirus type 1 at a higher dose D antigen units and less than 20 D-antigen units
展开▼